Hi! I’m Natasha Jacob. I am the Lead in Medical Product Development for Peak Pharm Labs. I have been working in pharmacy for over 20 years. I made a big change in 2018 when I decided to join the Hybridpharm team as their compounding specialist.

I needed something new. Cannabis was scheduled to be legalized in October 2018 and it was here to stay. I was very excited to be part of this new dynamic team. I was meeting with OBGYN healthcare professionals and educating them on cannabis and how it could help their patients. I was often asked, “Where are the studies?”

Back then some were very hard to find but they were there. There are so many organizations all over the world conducting studies on the effects of cannabis on various conditions. When we were looking into what was published for endometriosis and other vulvular conditions, we were shocked. There was so much data available. All over the world, endometriosis has become widely discussed and studied.

Just recently, French President Emmanuel Macron made endometriosis a legally recognized chronic illness. This boosted services for millions of women living with the painful and debilitating disease. Specialized centres are now being planned for France and Australia. Although still largely illegal, cannabis laws in Australia differ from state to state. From our friends down under, many amazing studies are coming out with regards to endometriosis and cannabis.

This study released October 26th, 2021 with help from Strainprint Technologies Ltd (located in Scarborough Ontario), focuses on the effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms. Enjoy!

Natasha Jacob- Lead in Medical Product Development

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0258940